Amyloidosis trials in Italy

In Italy 36 Also abroad 184

36 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
The Italian Transthyretin Amyloidosis Web-Network
Where
Ancona, Bari, Bergamo, Brescia, Cagliari, Cosenza, Ivrea, Legnano, Milan, Monza, Orbassano, Padova, Pavia, Perugia, Pescara, Roma, Salerno, Sassari, Siena, Torino, Treviglio, Vercelli, Vicenza
Age
18 years to 99 years
People
1,000
Run by
Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT05444920
No phaseTaking people
Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment
Where
Pavia
Age
18 years to 99 years
People
100
Run by
Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT07448779
Phase 4Not yet taking people in Italy
HeArt Rate and quality of Life in transthyrEtin cardiac amYloidosis (HARLEY)
Where
Firenze, Genova, Roma
Age
18 years and over
People
104
Run by
Universita' Degli Studi Di Genova
See details and how to join2024-519107-10-00 · EU 2024-519107-10-00
No phaseTaking people
An Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Program for Patients, Caregivers, and Presymptomatic Carriers in Hereditary Transthyretin Amyloidosis With Cardiomyopathy
Where
Pavia
Age
18 years and over
People
150
Run by
Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT06907186
No phaseTaking people
International Cardiac Amyloidosis Registry
Where
Roma
Age
18 years and over
People
300 worldwide
Run by
Leiden University Medical Center
See details and how to joinNCT06894290
No phaseTaking people
Observational Epidemiological Study of Patients Suffering From Systemic Amyloidosis
Where
Bologna
Age
18 years to 99 years
People
750
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06866912
No phaseTaking people
A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.
Where
Brescia, Ferrara, Trieste
Age
18 years and over
People
600 worldwide
Run by
Medical University of Vienna
See details and how to joinNCT06836011
No phaseTaking people
Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation
Where
Bologna, Florence, Roma
Age
12 years and over
People
700
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06813443
No phaseTaking people
MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardiac Amyloidosis
Where
Milan
Age
18 years to 100 years
People
1,400
Run by
Centro Cardiologico Monzino
See details and how to joinNCT06799273
Phase 3Taking people
A multi-center phase 3 study of 18F-florbetaben positron emission tomography/computed tomography (PET-CT) to non-invasively diagnose cardiac AL amyloidosis: the PETAL study.
Where
Bergamo, Ferrara, Naples, Pavia, Pisa, Trieste
Age
18 years and over
People
150
Run by
Fondazione Toscana Gabriele Monasterio
See details and how to join2024-517942-33-03 · EU 2024-517942-33-03
Phase 2Taking people
Effect of dapagliflozin on the quality of life and exercise capacity of patients with amyloid transthyretin cardiac amyloidosis: a pilot, phase 2b study
Where
Pisa
Age
18 years and over
People
50
Run by
Fondazione Toscana Gabriele Monasterio
See details and how to join2023-504041-31-00 · EU 2023-504041-31-00